Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Medical Care Facilities

Global Health Limited engages in the provision of healthcare services in India. The company primarily offers treatments in the areas of digestive and hepatobiliary sciences, cardiac and cancer care, neurosciences, gastrosciences, musculoskeletal disorders and orthopaedics, renal care, liver transplant, lung transplant, bone marrow transplant, chest surgery, gynaecology and gynaeoncology, paediatric care, obstetrics, plastic, aesthetic and reconstructive surgery, ENT, head and neck surgery, internal medicine, respiratory and sleep medicine, peripheral vascular and endovascular sciences, endocrinology and diabetes, rheumatology and immunology, radiology and imaging, ophthalmology, critical care, dermatology, dentistry, ayurveda, and dietetics and nutrition. It also offers lab tests and diagnostics, homecare and elder care services, telemedicine and air ambulance services, blood bank and e-ICU services, and health plans, as well as operates pharmacies. The company operates a network of hospitals under the Medanta brand. Global Health Limited was incorporated in 2004 and is based in New Delhi, India.

Revenue projections:

Revenue projections for MEDANTA
Revenue projections for MEDANTA

Investors are expected to be cautious with MEDANTA, as its revenues are projected to fall compared to last year. A decline in revenue often results in a negative impact on profitability, prompting concerns about the company's financial stability and making investors more conservative in their approach.

Financial Ratios:

currentRatio 2.47800
forwardPE 42.17283
debtToEquity 21.18800
earningsGrowth -0.20400
revenueGrowth 0.12800
grossMargins 0.53844
operatingMargins 0.18839
trailingEps 17.91000
forwardEps 23.41000

MEDANTA's current ratio 2.478, suggesting the company has sufficient liquidity to service its short-term debt. With its cash reserves and current assets in good shape, MEDANTA can comfortably meet its immediate liabilities, reflecting a healthy financial standing.
MEDANTA's low Debt-to-Equity ratio demonstrates that the company is not over-leveraged. This means it maintains a healthy balance between debt and equity, lowering financial risk and contributing to overall financial stability, which could attract risk-averse investors.
MEDANTA's low earnings and revenue growth suggest that its profits could shrink. This points to a potential downturn in the company's financial outlook and may indicate challenges in maintaining profitability.
With negative gross and operating margins, MEDANTA is facing losses at both the production and operational levels. This signals significant financial strain and may indicate that the company is struggling to manage costs effectively.
MEDANTA's forward EPS being higher than its trailing EPS suggests that the company is expected to generate stronger profits this year. This points to improving financial performance, with MEDANTA anticipated to deliver better earnings than it did in the prior year.

Price projections:

Price projections for MEDANTA
Price projections for MEDANTA

Price projections for MEDANTA have been gradually lowered, signaling reduced optimism among analysts. This downward adjustment suggests that the company may face challenges in meeting previous growth expectations.

Recommendation changes over time:

Recommendations trend for MEDANTA
Recommendations trend for MEDANTA


Analysts' recent buy bias toward MEDANTA suggests the stock is gaining favor as a strong investment choice. This optimism could drive more investors to see MEDANTA as a smart place to invest, further bolstering confidence in the company's long-term growth and potential returns.